The deal priced below last closing price of $2.55. Berenberg is acting as sole book running manager for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATAI:
- Atai Life Sciences announces $55M common shares offering
- Psychedelic: Relmada acquires neurosteroid from Asarina
- Biotech Alert: Searches spiking for these stocks today
- Psychedelic: atai Life Sciences reports BPL-003 study results
- Atai Life Sciences announces results from BPL-003 Phase 2a open-label study